| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.697 | 0.003 | 0.697 | Peroxidase inhibitor | 0.525 0.008 CID_92043695 | ||
| 0.615 | 0.006 | 0.615 | GABA C receptor rho-3 antagonist | 0.355 0.083 CID_92043695 | ||
| 0.504 | 0.027 | 0.504 | Histamine release inhibitor | 0.5 0.029 CID_92043695 | ||
| 0.422 | 0.005 | 0.422 | GABA C receptor agonist | 0.148 0.035 CID_92043695 | ||
| 0.416 | 0.019 | 0.416 | Calcium channel activator | 0.326 0.068 CID_92043695 | ||
| 0.427 | 0.043 | 0.427 | Aldehyde oxidase inhibitor | |||
| 0.407 | 0.026 | 0.59 | Superoxide dismutase inhibitor | 0.59 0.007 CID_92043695 | CID_92043695 | |
| 0.383 | 0.007 | 0.383 | Protein kinase (CK1) gamma 3 inhibitor | 0.224 0.036 CID_92043695 | ||
| 0.381 | 0.01 | 0.381 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.141 0.084 CID_92043695 | ||
| 0.366 | 0.004 | 0.366 | Nitric-oxide synthase stimulant | 0.218 0.063 CID_92043695 | ||
| 0.368 | 0.015 | 0.368 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.172 0.1 CID_92043695 | ||
| 0.424 | 0.08 | 0.424 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.272 0.253 CID_92043695 | ||
| 0.408 | 0.076 | 0.408 | Calcium channel L-type activator | |||
| 0.341 | 0.014 | 0.341 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.346 | 0.022 | 0.346 | MAP kinase kinase 2 inhibitor | |||
| 0.37 | 0.052 | 0.37 | 5 Hydroxytryptamine release stimulant | |||
| 0.33 | 0.013 | 0.33 | Protein kinase (CK1) gamma inhibitor | 0.133 0.078 CID_92043695 | ||
| 0.342 | 0.027 | 0.342 | Death-associated protein kinase 3 inhibitor | |||
| 0.321 | 0.011 | 0.321 | Aurora-A kinase inhibitor | |||
| 0.368 | 0.067 | 0.368 | Vasodilator, peripheral | |||
| 0.305 | 0.006 | 0.305 | MAP kinase kinase 3 inhibitor | 0.258 0.024 CID_92043695 | ||
| 0.384 | 0.088 | 0.384 | 5 Hydroxytryptamine release inhibitor | |||
| 0.305 | 0.009 | 0.305 | Cystathionine beta-synthase inhibitor | |||
| 0.298 | 0.005 | 0.298 | Porphobilinogen synthase inhibitor | 0.145 0.021 CID_92043695 | ||
| 0.324 | 0.032 | 0.324 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.331 | 0.042 | 0.331 | Dyrk kinase inhibitor | |||
| 0.311 | 0.03 | 0.311 | Anesthetic general | |||
| 0.322 | 0.043 | 0.322 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.297 | 0.022 | 0.297 | LIM domain kinase 1 inhibitor | |||
| 0.39 | 0.117 | 0.39 | Caspase 9 stimulant | |||
| 0.278 | 0.006 | 0.458 | Protein kinase C zeta inhibitor | 0.458 0.003 CID_92043695 | CID_92043695 | |
| 0.311 | 0.04 | 0.311 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.302 | 0.031 | 0.45 | RNA-directed DNA polymerase inhibitor | 0.45 0.014 CID_92043695 | CID_92043695 | |
| 0.282 | 0.014 | 0.282 | Protein kinase (CK1) gamma 2 inhibitor | 0.111 0.073 CID_92043695 | ||
| 0.307 | 0.042 | 0.307 | Antimitotic | 0.199 0.084 CID_92043695 | ||
| 0.283 | 0.023 | 0.283 | Neurotrophic factor enhancer | |||
| 0.255 | 0.005 | 0.255 | Alcohol oxidase inhibitor | |||
| 0.257 | 0.01 | 0.257 | GABA C receptor rho-2 antagonist | 0.128 0.109 CID_92043695 | ||
| 0.25 | 0.003 | 0.25 | Sodium/calcium exchanger inhibitor | 0.153 0.004 CID_92043695 | ||
| 0.283 | 0.042 | 0.283 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.267 | 0.031 | 0.267 | Protein kinase C nu inhibitor | |||
| 0.254 | 0.019 | 0.254 | Ribosomal protein S6 kinase inhibitor | |||
| 0.256 | 0.025 | 0.256 | Tubulin antagonist | |||
| 0.284 | 0.054 | 0.284 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.232 | 0.008 | 0.232 | GABA C receptor antagonist | 0.196 0.014 CID_92043695 | ||
| 0.265 | 0.041 | 0.265 | CDC-like kinase 2 inhibitor | |||
| 0.226 | 0.005 | 0.226 | Phenylalanine 4-hydroxylase inhibitor | 0.098 0.027 CID_92043695 | ||
| 0.238 | 0.019 | 0.238 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.273 | 0.054 | 0.273 | DNA synthesis inhibitor | 0.201 0.121 CID_92043695 | ||
| 0.254 | 0.049 | 0.254 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.282 | 0.078 | 0.282 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.249 | 0.045 | 0.249 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.21 | 0.007 | 0.21 | GABA C receptor rho-1 antagonist | 0.092 0.074 CID_92043695 | ||
| 0.293 | 0.095 | 0.462 | Cholesterol antagonist | 0.462 0.039 CID_92043695 | CID_92043695 | |
| 0.209 | 0.012 | 0.209 | Histidine decarboxylase inhibitor | |||
| 0.311 | 0.125 | 0.311 | MAP kinase kinase 6 inhibitor | |||
| 0.197 | 0.011 | 0.197 | Creatine kinase inhibitor | 0.11 0.049 CID_92043695 | ||
| 0.222 | 0.038 | 0.222 | Heat shock protein 90 alpha antagonist | |||
| 0.204 | 0.02 | 0.204 | CF transmembrane conductance regulator agonist | |||
| 0.234 | 0.05 | 0.234 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.207 | 0.032 | 0.207 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.226 | 0.051 | 0.226 | I kappa B kinase epsilon inhibitor | |||
| 0.227 | 0.055 | 0.227 | CDC-like kinase 4 inhibitor | |||
| 0.233 | 0.062 | 0.233 | Clk dual-specificity kinase inhibitor | |||
| 0.243 | 0.073 | 0.623 | Angiogenesis stimulant | 0.623 0.006 CID_92043695 | CID_92043695 | |
| 0.256 | 0.091 | 0.256 | Insulysin inhibitor | |||
| 0.172 | 0.007 | 0.172 | Purinergic P2X2 antagonist | 0.157 0.01 CID_92043695 | ||
| 0.172 | 0.008 | 0.172 | Alpha tubulin antagonist | |||
| 0.208 | 0.043 | 0.208 | Succinate dehydrogenase inhibitor | 0.153 0.107 CID_92043695 | ||
| 0.298 | 0.133 | 0.306 | 15-Lipoxygenase inhibitor | 0.306 0.128 CID_92043695 | CID_92043695 | |
| 0.206 | 0.044 | 0.206 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.224 | 0.064 | 0.224 | DNA methylase inhibitor | |||
| 0.196 | 0.038 | 0.196 | Hexokinase inhibitor | |||
| 0.262 | 0.105 | 0.262 | Interleukin 2 agonist | |||
| 0.2 | 0.044 | 0.269 | Phospholipase C inhibitor | 0.269 0.022 CID_92043695 | CID_92043695 | |
| 0.191 | 0.036 | 0.191 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.194 | 0.041 | 0.194 | Heat shock protein 90 antagonist | |||
| 0.163 | 0.01 | 0.333 | Acetylcholine release stimulant | 0.333 0.003 CID_92043695 | CID_92043695 | |
| 0.171 | 0.019 | 0.171 | HIV-1 integrase (Overall Integration) inhibitor | 0.113 0.044 CID_92043695 | ||
| 0.165 | 0.014 | 0.165 | NADH dehydrogenase inhibitor | 0.109 0.035 CID_92043695 | ||
| 0.169 | 0.02 | 0.169 | Adenylate kinase inhibitor | 0.126 0.039 CID_92043695 | ||
| 0.163 | 0.015 | 0.163 | DOPA decarboxylase inhibitor | |||
| 0.207 | 0.06 | 0.207 | Histone acetyltransferase inhibitor | |||
| 0.231 | 0.084 | 0.231 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.17 | 0.023 | 0.17 | Interleukin 8 antagonist | |||
| 0.175 | 0.03 | 0.175 | Adenylate cyclase stimulant | 0.172 0.034 CID_92043695 | ||
| 0.189 | 0.044 | 0.189 | Arachidonic acid antagonist | |||
| 0.168 | 0.024 | 0.168 | UDP-glucose 4-epimerase inhibitor | |||
| 0.148 | 0.009 | 0.148 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.058 0.037 CID_92043695 | ||
| 0.168 | 0.029 | 0.168 | Beta amyloid protein antagonist | 0.153 0.038 CID_92043695 | ||
| 0.152 | 0.013 | 0.152 | Histamine N-methyltransferase inhibitor | 0.08 0.066 CID_92043695 | ||
| 0.204 | 0.067 | 0.204 | DNA methyltransferase I inhibitor | |||
| 0.154 | 0.017 | 0.154 | Rho-associated kinase II inhibitor | |||
| 0.163 | 0.027 | 0.163 | Carbonic anhydrase XV inhibitor | 0.126 0.042 CID_92043695 | ||
| 0.14 | 0.007 | 0.14 | Protein kinase C epsilon inhibitor | |||
| 0.199 | 0.066 | 0.199 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.158 | 0.027 | 0.158 | Protein kinase C gamma inhibitor | |||
| 0.148 | 0.017 | 0.148 | I kappa B kinase inhibitor | |||
| 0.158 | 0.027 | 0.158 | Ca2+-transporting ATPase inhibitor | |||
| 0.188 | 0.059 | 0.188 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.143 | 0.014 | 0.143 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.148 | 0.019 | 0.148 | Rho-associated kinase inhibitor | |||
| 0.162 | 0.036 | 0.162 | Protein kinase (CK2) alpha inhibitor | |||
| 0.135 | 0.009 | 0.135 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.175 | 0.049 | 0.175 | Activin receptor-like kinase 2 inhibitor | |||
| 0.169 | 0.044 | 0.169 | NADPH oxidase inhibitor | |||
| 0.164 | 0.04 | 0.164 | Nav1.6 sodium channel blocker | |||
| 0.172 | 0.048 | 0.172 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.188 | 0.065 | 0.188 | Lipocortins synthesis antagonist | |||
| 0.217 | 0.094 | 0.217 | Aryl hydrocarbon receptor agonist | |||
| 0.162 | 0.04 | 0.162 | Interleukin 4 antagonist | |||
| 0.222 | 0.101 | 0.222 | Interleukin agonist | |||
| 0.164 | 0.044 | 0.164 | MAP kinase kinase inhibitor | 0.099 0.096 CID_92043695 | ||
| 0.163 | 0.043 | 0.184 | Glutamate receptor antagonist | 0.184 0.031 CID_92043695 | CID_92043695 | |
| 0.245 | 0.127 | 0.728 | Angiogenesis inhibitor | 0.728 0.008 CID_92043695 | CID_92043695 | |
| 0.14 | 0.023 | 0.14 | Electrolyte absorption antagonist | |||
| 0.173 | 0.057 | 0.173 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.25 | 0.135 | 0.25 | Vasodilator, coronary | |||
| 0.292 | 0.178 | 0.292 | Apoptosis agonist | |||
| 0.157 | 0.043 | 0.157 | Aldehyde dehydrogenase inhibitor | |||
| 0.136 | 0.023 | 0.136 | MAP kinase kinase 1 inhibitor | |||
| 0.143 | 0.031 | 0.143 | Carbonic anhydrase III inhibitor | 0.132 0.037 CID_92043695 | ||
| 0.191 | 0.079 | 0.191 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.133 | 0.022 | 0.133 | Phosphofructokinase-1 inhibitor | 0.07 0.048 CID_92043695 | ||
| 0.133 | 0.021 | 0.133 | Toll-Like receptor 3 antagonist | |||
| 0.172 | 0.062 | 0.172 | Interleukin 6 antagonist | |||
| 0.14 | 0.031 | 0.14 | Pim-1 kinase inhibitor | |||
| 0.119 | 0.011 | 0.119 | Transforming growth factor beta 3 antagonist | 0.079 0.069 CID_92043695 | ||
| 0.132 | 0.025 | 0.132 | Pim-3 kinase inhibitor | |||
| 0.15 | 0.044 | 0.15 | Histone deacetylase class III inhibitor | |||
| 0.144 | 0.039 | 0.144 | 5 Hydroxytryptamine 3A agonist | |||
| 0.124 | 0.019 | 0.124 | Glutamate decarboxylase inhibitor | 0.065 0.061 CID_92043695 | ||
| 0.119 | 0.016 | 0.119 | Carbamoyl phosphate synthetase inhibitor | 0.083 0.027 CID_92043695 | ||
| 0.118 | 0.015 | 0.118 | I kappa B kinase 1 inhibitor | |||
| 0.143 | 0.041 | 0.143 | Ferrochelatase inhibitor | |||
| 0.265 | 0.163 | 0.48 | Antibacterial | 0.48 0.046 CID_92043695 | CID_92043695 | |
| 0.139 | 0.038 | 0.139 | Protein kinase (CK2) inhibitor | |||
| 0.117 | 0.015 | 0.117 | D-Ala-D-Ala ligase inhibitor | |||
| 0.11 | 0.009 | 0.11 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.092 0.02 CID_92043695 | ||
| 0.13 | 0.029 | 0.13 | Alcohol dehydrogenase inhibitor | |||
| 0.226 | 0.125 | 0.226 | 12-Lipoxygenase inhibitor | |||
| 0.158 | 0.061 | 0.158 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.155 | 0.058 | 0.155 | Histone deacetylase SIRT1 inhibitor | |||
| 0.112 | 0.016 | 0.112 | Transforming growth factor antagonist | |||
| 0.122 | 0.026 | 0.122 | CYP2A6 inhibitor | |||
| 0.142 | 0.047 | 0.142 | MAP kinase 12 inhibitor | |||
| 0.152 | 0.058 | 0.152 | MAP kinase kinase 4 inhibitor | |||
| 0.155 | 0.061 | 0.317 | Cell wall synthesis inhibitor | 0.317 0.009 CID_92043695 | CID_92043695 | |
| 0.204 | 0.112 | 0.204 | DNA damaging | |||
| 0.114 | 0.023 | 0.114 | Myeloperoxidase inhibitor | |||
| 0.105 | 0.015 | 0.105 | Purinergic P2X1 antagonist | 0.057 0.048 CID_92043695 | ||
| 0.146 | 0.056 | 0.146 | Heat shock protein 70 antagonist | |||
| 0.101 | 0.012 | 0.101 | MAP kinase kinase 7 inhibitor | |||
| 0.134 | 0.045 | 0.134 | MAP kinase 13 inhibitor | |||
| 0.113 | 0.025 | 0.113 | Glutamate dehydrogenase inhibitor | 0.073 0.052 CID_92043695 | ||
| 0.099 | 0.011 | 0.099 | Heat shock protein 90 beta antagonist | |||
| 0.177 | 0.091 | 0.177 | Focal adhesion kinase 2 inhibitor | |||
| 0.16 | 0.074 | 0.16 | Polo-like kinase-3 inhibitor | |||
| 0.116 | 0.031 | 0.116 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.155 | 0.072 | 0.155 | Interferon gamma antagonist | |||
| 0.161 | 0.078 | 0.161 | Neurotensin receptor agonist | |||
| 0.15 | 0.068 | 0.15 | Protein kinase stimulant | |||
| 0.117 | 0.035 | 0.117 | Protein kinase A inhibitor | |||
| 0.107 | 0.026 | 0.107 | Protein kinase B alpha inhibitor | |||
| 0.135 | 0.054 | 0.135 | CC chemokine 6 receptor antagonist | |||
| 0.099 | 0.019 | 0.099 | Biliverdin reductase inhibitor | |||
| 0.105 | 0.025 | 0.105 | Histone deacetylase SIRT2 inhibitor | |||
| 0.093 | 0.015 | 0.093 | Glutamate (mGluR7) antagonist | |||
| 0.147 | 0.07 | 0.147 | Protein kinase (CK1) inhibitor | |||
| 0.09 | 0.012 | 0.09 | Botulinum neurotoxin type A inhibitor | |||
| 0.081 | 0.004 | 0.081 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.051 0.014 CID_92043695 | ||
| 0.109 | 0.032 | 0.109 | Glutamate release inhibitor | |||
| 0.148 | 0.071 | 0.148 | MAP kinase 3 inhibitor | |||
| 0.098 | 0.023 | 0.098 | Beta tubulin antagonist | |||
| 0.087 | 0.011 | 0.087 | Aconitate hydratase inhibitor | |||
| 0.14 | 0.065 | 0.14 | Interleukin 1 antagonist | |||
| 0.106 | 0.032 | 0.106 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.212 | 0.138 | 0.212 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.142 | 0.069 | 0.142 | Pregnane X receptor agonist | 0.131 0.097 CID_92043695 | ||
| 0.086 | 0.013 | 0.086 | Transcription factor RelA inhibitor | |||
| 0.102 | 0.029 | 0.102 | Keratolytic | |||
| 0.084 | 0.012 | 0.084 | Topoisomerase II beta inhibitor | |||
| 0.087 | 0.016 | 0.087 | Bombesin 3 receptor antagonist | |||
| 0.092 | 0.021 | 0.092 | Argininosuccinate synthase inhibitor | |||
| 0.136 | 0.066 | 0.136 | Toll-Like receptor antagonist | |||
| 0.112 | 0.042 | 0.112 | Protein kinase C delta inhibitor | |||
| 0.089 | 0.02 | 0.089 | Xanthine dehydrogenase inhibitor | |||
| 0.1 | 0.031 | 0.1 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.127 | 0.059 | 0.127 | DNA repair enzyme inhibitor | |||
| 0.074 | 0.006 | 0.074 | Geranyltranstransferase inhibitor | |||
| 0.199 | 0.132 | 0.199 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.126 | 0.06 | 0.126 | Aurora-B kinase inhibitor | |||
| 0.119 | 0.053 | 0.179 | Aminopeptidase B inhibitor | 0.179 0.027 CID_92043695 | CID_92043695 | |
| 0.09 | 0.024 | 0.09 | Aromatase inhibitor | 0.068 0.035 CID_92043695 | ||
| 0.096 | 0.03 | 0.096 | Estrogen-related receptor beta agonist | |||
| 0.091 | 0.025 | 0.091 | GABA B receptor agonist | |||
| 0.107 | 0.042 | 0.306 | Triose-phosphate isomerase inhibitor | 0.306 0.005 CID_92043695 | CID_92043695 | |
| 0.072 | 0.007 | 0.072 | Dopamine beta hydroxylase inhibitor | |||
| 0.166 | 0.103 | 0.166 | Pyruvate kinase inhibitor | |||
| 0.086 | 0.023 | 0.086 | Potassium channel (ATP-sensitive) blocker | |||
| 0.118 | 0.055 | 0.118 | Chelator | |||
| 0.178 | 0.116 | 0.178 | Antiamyloidogenic | |||
| 0.124 | 0.064 | 0.124 | Topoisomerase II inhibitor | |||
| 0.142 | 0.081 | 0.142 | NOS3 expression enhancer | |||
| 0.086 | 0.026 | 0.086 | MAP kinase 7 inhibitor | |||
| 0.12 | 0.06 | 0.12 | Microtubule formation inhibitor | |||
| 0.07 | 0.01 | 0.07 | Urate transporter 1 inhibitor | |||
| 0.078 | 0.019 | 0.078 | Cyclin D1 inhibitor | |||
| 0.092 | 0.033 | 0.092 | GABA aminotransferase inhibitor | |||
| 0.105 | 0.047 | 0.105 | Interleukin 12 antagonist | |||
| 0.211 | 0.153 | 0.211 | Caspase 3 stimulant | |||
| 0.097 | 0.041 | 0.097 | Carbonic anhydrase VI inhibitor | 0.092 0.045 CID_92043695 | ||
| 0.087 | 0.031 | 0.087 | CDC7 inhibitor | |||
| 0.079 | 0.023 | 0.079 | I kappa B kinase 2 inhibitor | |||
| 0.072 | 0.016 | 0.072 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.213 | 0.157 | 0.213 | Transcription factor NF kappa B inhibitor | |||
| 0.115 | 0.059 | 0.115 | Activin receptor-like kinase 4 inhibitor | |||
| 0.109 | 0.054 | 0.109 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.126 | 0.072 | 0.126 | Toll-Like receptor 2 antagonist | |||
| 0.107 | 0.054 | 0.133 | Anabolic | 0.133 0.028 CID_92043695 | CID_92043695 | |
| 0.067 | 0.015 | 0.067 | Adenosine deaminase inhibitor | 0.063 0.018 CID_92043695 | ||
| 0.076 | 0.024 | 0.076 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.115 | 0.064 | 0.115 | Photosensitizer | |||
| 0.122 | 0.072 | 0.122 | Protein kinase (CK1) delta inhibitor | |||
| 0.061 | 0.012 | 0.061 | Dopamine D5 agonist | |||
| 0.125 | 0.077 | 0.125 | Vanilloid 1 agonist | |||
| 0.085 | 0.038 | 0.085 | Nav1.8 sodium channel blocker | 0.071 0.055 CID_92043695 | ||
| 0.123 | 0.077 | 0.162 | Cyclooxygenase 1 inhibitor | 0.162 0.051 CID_92043695 | CID_92043695 | |
| 0.081 | 0.035 | 0.081 | Secretase beta inhibitor | |||
| 0.136 | 0.091 | 0.136 | Phospholipase A2 inhibitor | 0.131 0.099 CID_92043695 | ||
| 0.082 | 0.037 | 0.082 | Glycine receptor agonist | |||
| 0.083 | 0.039 | 0.083 | Aminopeptidase I inhibitor | |||
| 0.147 | 0.104 | 0.147 | Tumour necrosis factor antagonist | |||
| 0.056 | 0.013 | 0.056 | Dihydropteroate synthase inhibitor | 0.035 0.034 CID_92043695 | ||
| 0.133 | 0.091 | 0.45 | Hemostatic | 0.45 0.005 CID_92043695 | CID_92043695 | |
| 0.102 | 0.061 | 0.102 | MAP kinase 9 inhibitor | |||
| 0.085 | 0.045 | 0.085 | Macrophage migration inhibitory factor inhibitor | |||
| 0.121 | 0.081 | 0.121 | Amylase inhibitor | |||
| 0.073 | 0.033 | 0.073 | 5 Hydroxytryptamine 3 agonist | |||
| 0.051 | 0.011 | 0.051 | Glutamate (mGluR8) agonist | |||
| 0.127 | 0.088 | 0.127 | CDC-like kinase 1 inhibitor | |||
| 0.087 | 0.048 | 0.087 | Acetylcholine nicotinic agonist | |||
| 0.063 | 0.024 | 0.063 | Dihydroorotate oxidase inhibitor | |||
| 0.175 | 0.137 | 0.175 | Peptidyltransferase inhibitor | |||
| 0.073 | 0.035 | 0.073 | Glutamate (mGluR6) antagonist | |||
| 0.08 | 0.043 | 0.218 | NMDA 2 receptor antagonist | 0.218 0.008 CID_92043695 | CID_92043695 | |
| 0.044 | 0.008 | 0.044 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.106 | 0.07 | 0.106 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.066 | 0.03 | 0.066 | Beta 1 adrenoreceptor antagonist | |||
| 0.095 | 0.059 | 0.095 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.051 | 0.016 | 0.051 | Alpha 1d adrenoreceptor agonist | |||
| 0.087 | 0.053 | 0.087 | MAP-kinase-activated kinase inhibitor | |||
| 0.068 | 0.035 | 0.086 | NMDA 2C receptor antagonist | 0.086 0.022 CID_92043695 | CID_92043695 | |
| 0.082 | 0.049 | 0.087 | Interferon agonist | 0.087 0.042 CID_92043695 | CID_92043695 | |
| 0.086 | 0.054 | 0.086 | mTOR complex 2 inhibitor | |||
| 0.096 | 0.064 | 0.096 | Xanthine oxidase inhibitor | |||
| 0.05 | 0.018 | 0.05 | Nerve growth factor antagonist | |||
| 0.1 | 0.069 | 0.1 | Mediator release inhibitor | |||
| 0.078 | 0.047 | 0.078 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.066 | 0.036 | 0.066 | Protein kinase C iota inhibitor | |||
| 0.065 | 0.036 | 0.065 | Histone deacetylase SIRT3 inhibitor | |||
| 0.064 | 0.035 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.044 | 0.015 | 0.044 | VCAM-1 antagonist | |||
| 0.067 | 0.039 | 0.073 | Interferon inducer | 0.073 0.03 CID_92043695 | CID_92043695 | |
| 0.044 | 0.016 | 0.044 | VCAM antagonist | |||
| 0.059 | 0.031 | 0.059 | Epithelial sodium channel blocker | |||
| 0.053 | 0.026 | 0.053 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.045 | 0.018 | 0.045 | Diamine oxidase inhibitor | |||
| 0.139 | 0.112 | 0.139 | TRKC antagonist | |||
| 0.036 | 0.009 | 0.036 | Purinergic P2Y15 antagonist | |||
| 0.037 | 0.01 | 0.037 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.092 | 0.065 | 0.092 | Prolactin inhibitor | |||
| 0.059 | 0.032 | 0.059 | Pim-2 kinase inhibitor | |||
| 0.04 | 0.013 | 0.04 | Protein kinase (CK2) beta inhibitor | |||
| 0.044 | 0.018 | 0.044 | Potassium channel Kv1.1 blocker | |||
| 0.141 | 0.115 | 0.141 | Amyloid beta aggregation inhibitor | |||
| 0.07 | 0.045 | 0.07 | Neuronal nicotinic receptor antagonist | |||
| 0.101 | 0.077 | 0.101 | Mucolytic | |||
| 0.069 | 0.045 | 0.069 | Exportin-1 inhibitor | |||
| 0.077 | 0.053 | 0.077 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.101 | 0.077 | 0.101 | CDC-like kinase 3 inhibitor | |||
| 0.041 | 0.018 | 0.054 | Phosphoglycerate kinase inhibitor | 0.054 0.013 CID_92043695 | CID_92043695 | |
| 0.059 | 0.036 | 0.153 | Carbonic anhydrase VB inhibitor | 0.153 0.009 CID_92043695 | CID_92043695 | |
| 0.08 | 0.058 | 0.08 | Adrenaline agonist | |||
| 0.062 | 0.04 | 0.062 | Alpha 2 adrenoreceptor agonist | |||
| 0.049 | 0.026 | 0.049 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.06 | 0.038 | 0.06 | Ryanodine receptor antagonist | |||
| 0.056 | 0.034 | 0.056 | Ornithine carbamoyltransferase inhibitor | |||
| 0.068 | 0.047 | 0.068 | Check point kinase 1 inhibitor | |||
| 0.05 | 0.029 | 0.05 | Cytokine production stimulant | |||
| 0.104 | 0.084 | 0.11 | Alkylator | 0.11 0.078 CID_92043695 | CID_92043695 | |
| 0.094 | 0.074 | 0.094 | Urease inhibitor | |||
| 0.153 | 0.134 | 0.153 | Growth factor agonist | |||
| 0.057 | 0.037 | 0.057 | Maillard reaction inhibitor | |||
| 0.051 | 0.032 | 0.051 | Carbonic anhydrase XIV inhibitor | |||
| 0.072 | 0.053 | 0.072 | Protein kinase B beta inhibitor | |||
| 0.05 | 0.031 | 0.05 | AMPA receptor antagonist | |||
| 0.074 | 0.055 | 0.261 | Carbonic anhydrase XIII inhibitor | 0.261 0.008 CID_92043695 | CID_92043695 | |
| 0.07 | 0.052 | 0.098 | Phospholipase D inhibitor | 0.098 0.016 CID_92043695 | CID_92043695 | |
| 0.038 | 0.02 | 0.038 | Fumarate hydratase inhibitor | |||
| 0.052 | 0.034 | 0.052 | Beta 2 adrenoreceptor antagonist | |||
| 0.033 | 0.016 | 0.033 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.091 | 0.073 | 0.091 | Phosphodiesterase 6D inhibitor | |||
| 0.096 | 0.079 | 0.096 | Alpha 2b adrenoreceptor antagonist | |||
| 0.064 | 0.047 | 0.318 | Selectin antagonist | 0.318 0.005 CID_92043695 | CID_92043695 | |
| 0.023 | 0.006 | 0.023 | Nicotinic acid receptor 1 antagonist | |||
| 0.045 | 0.029 | 0.045 | AICAR transformylase inhibitor | |||
| 0.035 | 0.021 | 0.035 | Glutamate (mGluR4) agonist | |||
| 0.16 | 0.146 | 0.297 | Immunostimulant | 0.297 0.079 CID_92043695 | CID_92043695 | |
| 0.043 | 0.029 | 0.043 | Glutamate (mGluR group III) agonist | |||
| 0.179 | 0.165 | 0.179 | Lipoxygenase inhibitor | |||
| 0.053 | 0.04 | 0.053 | Thromboxane synthase inhibitor | |||
| 0.061 | 0.047 | 0.061 | Beta 2 adrenoreceptor agonist | |||
| 0.074 | 0.061 | 0.074 | Acetylcholine nicotinic antagonist | |||
| 0.155 | 0.143 | 0.155 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.139 | 0.126 | 0.139 | Psychostimulant | |||
| 0.071 | 0.059 | 0.092 | Na+ K+ transporting ATPase inhibitor | 0.092 0.039 CID_92043695 | CID_92043695 | |
| 0.09 | 0.078 | 0.186 | Gastric antisecretory | 0.186 0.015 CID_92043695 | CID_92043695 | |
| 0.055 | 0.043 | 0.055 | Pregnane X receptor antagonist | |||
| 0.021 | 0.01 | 0.021 | Cyclin T1 inhibitor | |||
| 0.043 | 0.032 | 0.059 | Dihydrofolate reductase inhibitor | 0.059 0.011 CID_92043695 | CID_92043695 | |
| 0.052 | 0.04 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | |||
| 0.036 | 0.026 | 0.036 | Glutamate (mGluR3) antagonist | |||
| 0.069 | 0.059 | 0.069 | Rho-associated kinase I inhibitor | |||
| 0.042 | 0.032 | 0.042 | Glutamate (mGluR4) antagonist | |||
| 0.106 | 0.096 | 0.106 | Cathepsin H inhibitor | |||
| 0.024 | 0.014 | 0.024 | ICAM 1 antagonist | |||
| 0.092 | 0.083 | 0.114 | DNA intercalator | 0.114 0.061 CID_92043695 | CID_92043695 | |
| 0.049 | 0.04 | 0.049 | mTOR inhibitor | |||
| 0.04 | 0.032 | 0.04 | Kainate receptor agonist | |||
| 0.046 | 0.038 | 0.046 | Transforming growth factor beta 1 antagonist | |||
| 0.053 | 0.045 | 0.053 | Immunoglobulin Fc receptor antagonist | |||
| 0.042 | 0.034 | 0.042 | Glutamate (mGluR group III) antagonist | |||
| 0.052 | 0.044 | 0.052 | Sphingosine kinase 2 inhibitor | |||
| 0.076 | 0.069 | 0.099 | Inducible nitric-oxide synthase inhibitor | 0.099 0.038 CID_92043695 | CID_92043695 | |
| 0.049 | 0.043 | 0.049 | Ribonucleotide reductase inhibitor | |||
| 0.048 | 0.042 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.088 | 0.081 | 0.094 | Nitric-oxide synthase inhibitor | 0.094 0.07 CID_92043695 | CID_92043695 | |
| 0.056 | 0.051 | 0.056 | Potassium channel (Ca-activated) blocker | |||
| 0.077 | 0.072 | 0.077 | Insulin growth factor antagonist | |||
| 0.049 | 0.044 | 0.512 | NMDA 2B receptor antagonist | 0.512 0.003 CID_92043695 | CID_92043695 | |
| 0.027 | 0.022 | 0.027 | Estrogen-related receptor gamma antagonist | |||
| 0.021 | 0.017 | 0.021 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.052 | 0.048 | 0.052 | EphB4 antagonist | |||
| 0.015 | 0.011 | 0.015 | Antibiotic Tetracycline-like | |||
| 0.028 | 0.024 | 0.028 | MAP3K8 inhibitor | |||
| 0.017 | 0.013 | 0.017 | CC chemokine 9 receptor antagonist | |||
| 0.016 | 0.012 | 0.016 | Nicotinic alpha4 receptor agonist | |||
| 0.097 | 0.094 | 0.097 | TRKA antagonist | |||
| 0.083 | 0.08 | 0.083 | Check point kinase 2 inhibitor | |||
| 0.007 | 0.004 | 0.007 | Insulin like growth factor 3 antagonist | |||
| 0.054 | 0.051 | 0.075 | Sphingosine kinase inhibitor | 0.075 0.02 CID_92043695 | CID_92043695 | |
| 0.192 | 0.19 | 0.192 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.018 | 0.016 | 0.018 | Antibiotic Anthracycline-like | |||
| 0.033 | 0.031 | 0.033 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.079 | 0.077 | 0.079 | Potassium channel (Ca-activated) activator | |||
| 0.014 | 0.013 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 CID_92043695 | CID_92043695 | |
| 0.038 | 0.037 | 0.038 | Histamine H2 receptor agonist | |||
| 0.062 | 0.061 | 0.062 | Glutamate (mGluR group I) antagonist | |||
| 0.059 | 0.058 | 0.059 | Beta adrenoreceptor antagonist | |||
| 0.041 | 0.04 | 0.041 | Thymidylate synthase inhibitor | |||
| 0.011 | 0.01 | 0.011 | Purine nucleoside phosphorylase inhibitor | |||
| 0.111 | 0.11 | 0.111 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.048 | 0.049 | 0.066 | Alpha-mannosidase inhibitor | 0.066 0.02 CID_92043695 | CID_92043695 | |
| 0.019 | 0.021 | 0.088 | Glutamate (mGluR1a) agonist | 0.088 0.004 CID_92043695 | CID_92043695 | |
| 0.059 | 0.063 | 0.162 | Carbonic anhydrase VA inhibitor | 0.162 0.009 CID_92043695 | CID_92043695 | |
| 0.104 | 0.109 | 0.131 | Alkaline phosphatase inhibitor | 0.131 0.074 CID_92043695 | CID_92043695 | |
| 0.104 | 0.11 | 0.114 | Antibacterial (Helicobacter pylori) | 0.114 0.09 CID_92043695 | CID_92043695 | |
| 0.038 | 0.045 | 0.058 | Mannosidase inhibitor | 0.058 0.018 CID_92043695 | CID_92043695 | |
| 0.052 | 0.063 | 0.088 | NMDA receptor agonist | 0.088 0.024 CID_92043695 | CID_92043695 | |
| 0.017 | 0.03 | 0.023 | Purinergic P2X agonist | 0.023 0.022 CID_92043695 | CID_92043695 | |
| 0.052 | 0.066 | 0.217 | Carbonic anhydrase V inhibitor | 0.217 0.005 CID_92043695 | CID_92043695 | |
| 0.017 | 0.033 | 0.052 | Kynurenine 3 monooxygenase inhibitor | 0.052 0.006 CID_92043695 | CID_92043695 | |
| 0.026 | 0.045 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.027 CID_92043695 | CID_92043695 | |
| 0.019 | 0.038 | 0.034 | Glutamate (mGluR1) agonist | 0.034 0.008 CID_92043695 | CID_92043695 | |
| 0.067 | 0.086 | 0.111 | NMDA receptor antagonist | 0.111 0.04 CID_92043695 | CID_92043695 | |
| 0.028 | 0.062 | 0.042 | Guanylate cyclase inhibitor | 0.042 0.03 CID_92043695 | CID_92043695 | |
| 0.023 | 0.058 | 0.064 | Purinergic P2Y2 antagonist | 0.064 0.007 CID_92043695 | CID_92043695 | |
| 0.176 | 0.211 | 0.366 | Antithrombotic | 0.366 0.059 CID_92043695 | CID_92043695 | |
| 0.063 | 0.099 | 0.116 | Fibroblast growth factor 1 antagonist | 0.116 0.045 CID_92043695 | CID_92043695 | |
| 0.032 | 0.071 | 0.046 | Glutamate (mGluR5) agonist | 0.046 0.031 CID_92043695 | CID_92043695 | |
| 0.08 | 0.119 | 0.124 | Cholesterol synthesis inhibitor | 0.124 0.062 CID_92043695 | CID_92043695 | |
| 0.047 | 0.086 | 0.104 | Catalase inhibitor | 0.104 0.037 CID_92043695 | CID_92043695 | |
| 0.013 | 0.058 | 0.028 | Dopamine D1 agonist | 0.028 0.01 CID_92043695 | CID_92043695 | |
| 0.026 | 0.074 | 0.044 | Glutamate (mGluR group I) agonist | 0.044 0.037 CID_92043695 | CID_92043695 | |
| 0.087 | 0.139 | 0.129 | Nav1.2 sodium channel blocker | 0.129 0.073 CID_92043695 | CID_92043695 | |
| 0.019 | 0.086 | 0.115 | Dopamine D2 agonist | 0.115 0.009 CID_92043695 | CID_92043695 | |
| 0.03 | 0.098 | 0.268 | HIV-1 integrase (Strand Transfer) inhibitor | 0.268 0.005 CID_92043695 | CID_92043695 | |
| 0.03 | 0.098 | 0.104 | H+/K+-transporting ATPase inhibitor | 0.104 0.008 CID_92043695 | CID_92043695 | |
| 0.035 | 0.116 | 0.224 | HIV-1 integrase (3'-Processing) inhibitor | 0.224 0.008 CID_92043695 | CID_92043695 | |
| 0.031 | 0.126 | 0.065 | Heparanase inhibitor | 0.065 0.016 CID_92043695 | CID_92043695 | |
| 0.045 | 0.149 | 0.096 | Glycine receptor antagonist | 0.096 0.036 CID_92043695 | CID_92043695 | |
| 0.018 | 0.136 | 0.099 | Carbonic anhydrase inhibitor | 0.099 0.027 CID_92043695 | CID_92043695 | |
| 0.011 | 0.134 | 0.043 | 1,3-Beta-glucan synthase inhibitor | 0.043 0.003 CID_92043695 | CID_92043695 | |
| 0.04 | 0.165 | 0.085 | HIV-1 integrase inhibitor | 0.085 0.034 CID_92043695 | CID_92043695 | |
| 0.078 | 0.204 | 0.406 | Diuretic | 0.406 0.013 CID_92043695 | CID_92043695 | |
| 0.036 | 0.166 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.009 CID_92043695 | CID_92043695 | |
| 0.011 | 0.143 | 0.106 | Factor Xa inhibitor | 0.106 0.013 CID_92043695 | CID_92043695 | |
| 0.103 | 0.247 | 0.252 | Antioxidant | 0.252 0.082 CID_92043695 | CID_92043695 | |
| 0.026 | 0.175 | 0.132 | Factor IXa inhibitor | 0.132 0.005 CID_92043695 | CID_92043695 | |
| 0.029 | 0.2 | 0.085 | Cathepsin G inhibitor | 0.085 0.04 CID_92043695 | CID_92043695 | |
| 0.05 | 0.239 | 0.219 | Thrombolytic | 0.219 0.043 CID_92043695 | CID_92043695 | |
| 0.027 | 0.22 | 0.129 | Thrombin inhibitor | 0.129 0.015 CID_92043695 | CID_92043695 | |
| 0.029 | 0.227 | 0.178 | CDC25A inhibitor | 0.178 0.009 CID_92043695 | CID_92043695 | |
| 0.007 | 0.21 | 0.072 | Estrogen agonist | 0.072 0.026 CID_92043695 | CID_92043695 | |
| 0.012 | 0.218 | 0.069 | Leukocyte elastase inhibitor | 0.069 0.015 CID_92043695 | CID_92043695 | |
| 0.045 | 0.281 | 0.143 | Nav1.4 sodium channel blocker | 0.143 0.037 CID_92043695 | CID_92043695 | |
| 0.018 | 0.27 | 0.077 | Neuraminidase (influenza) inhibitor | 0.077 0.027 CID_92043695 | CID_92043695 | |
| 0.033 | 0.286 | 0.073 | Chymotrypsin inhibitor | 0.073 0.065 CID_92043695 | CID_92043695 | |
| 0.008 | 0.263 | 0.123 | NMDA 2D receptor antagonist | 0.123 0.004 CID_92043695 | CID_92043695 | |
| 0.048 | 0.315 | 0.422 | Dual specificity phosphatase 3 inhibitor | 0.422 0.012 CID_92043695 | CID_92043695 | |
| 0.004 | 0.297 | 0.019 | Sodium/hydrogen exchanger inhibitor | 0.019 0.009 CID_92043695 | CID_92043695 | |
| 0.02 | 0.317 | 0.087 | MAP kinase kinase 10 inhibitor | 0.087 0.024 CID_92043695 | CID_92043695 | |
| 0.051 | 0.366 | 0.151 | Platelet antagonist | 0.151 0.143 CID_92043695 | CID_92043695 | |
| 0.042 | 0.359 | 0.417 | Dual specificity phosphatase inhibitor | 0.417 0.013 CID_92043695 | CID_92043695 | |
| 0.007 | 0.369 | 0.057 | Factor XIa inhibitor | 0.057 0.014 CID_92043695 | CID_92043695 | |
| 0.034 | 0.399 | 0.607 | Anticoagulant | 0.607 0.005 CID_92043695 | CID_92043695 | |
| 0.027 | 0.407 | 0.094 | Breast cancer-resistant protein inhibitor | 0.094 0.062 CID_92043695 | CID_92043695 | |
| 0.012 | 0.406 | 0.957 | Cholecystokinin B agonist | 0.957 0.001 CID_92043695 | CID_92043695 | |
| 0.02 | 0.447 | 0.303 | Protein-tyrosine phosphatase inhibitor | 0.303 0.018 CID_92043695 | CID_92043695 | |
| 0.037 | 0.473 | 0.354 | Platelet adhesion inhibitor | 0.354 0.019 CID_92043695 | CID_92043695 | |
| 0.097 | 0.536 | 0.391 | Antiinflammatory | 0.391 0.144 CID_92043695 | CID_92043695 | |
| 0.004 | 0.466 | 0.057 | Factor XI inhibitor | 0.057 0.008 CID_92043695 | CID_92043695 | |
| 0.021 | 0.487 | 0.259 | Multidrug resistance-associated protein 1 inhibitor | 0.259 0.005 CID_92043695 | CID_92043695 | |
| 0.006 | 0.541 | 0.103 | Protein-tyrosine phosphatase 1B inhibitor | 0.103 0.076 CID_92043695 | CID_92043695 | |
| 0.002 | 0.605 | 0.035 | Estrone sulfatase inhibitor | 0.035 0.009 CID_92043695 | CID_92043695 | |
| 0.003 | 0.68 | 0.843 | Cholecystokinin A agonist | 0.843 0.001 CID_92043695 | CID_92043695 | |
| 0.003 | 0.689 | 0.856 | Cholecystokinin agonist | 0.856 0.001 CID_92043695 | CID_92043695 | |
| 0.008 | 0.719 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.008 CID_92043695 | CID_92043695 | |
| 0.003 | 0.772 | 0.525 | Cholecystokinin A antagonist | 0.525 0.003 CID_92043695 | CID_92043695 | |
| 0.002 | 0.815 | 0.414 | Cholecystokinin B antagonist | 0.414 0.003 CID_92043695 | CID_92043695 | |
| 0.003 | 0.853 | 0.4 | Cholecystokinin antagonist | 0.4 0.003 CID_92043695 | CID_92043695 | |
| 0.004 | 0.89 | 0.085 | Elastase inhibitor | 0.085 0.014 CID_92043695 | CID_92043695 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |